Lung cancer

Alda Tam, MD
Alda Tam, MD, presents the case of a 60-year-old man with mesothelioma.
medical studies
A new study sought to determine if patient and facility demographics impacted overall survival in patients with early-stage non-small cell lung cancer (NSCLC) treated with radiofrequency (RF) ablation. Results published in the Journal of Vascular and Interventional Radiology found that patients… Read More
Lung
A new study found no significant difference in overall survival (OS) for patients with early-stage non–small cell lung cancer (NSCLC) treated with either radiofrequency (RF) ablation or stereotactic body radiotherapy (SBRT). The study was published by the Journal of Vascular and Interventional… Read More
Alice Gillams
Interventional oncologists often report that they have difficulty making the case for continuing to perform lung ablation, but many clinicians are convinced that lung ablation should remain within the scope of practice. Alice Gillams, MB, CHB, reviewed literature supporting lung ablation in a… Read More
lungs
LOS ANGELES—Treating lung cancer with radiofrequency ablation (RFA) at high-volume centers is linked with improved overall survival, researchers reported in a study presented at the annual meeting of the Society of Interventional Radiology. However, higher T-classification and increasing age were… Read More
packed hall
Morning sessions review lung ablation therapies and potential for emerging technologies. By Brenda Silva As CIO 2018 continues, early sessions on day two looked to report on existing and emerging technologies for ablation with focused attention on lung, thyroid, and lymph nodes, as well as… Read More
Stephen Solomon, MD
Lung ablation is an active area of research in interventional oncology, and recently published studies have given clinicians more factors to consider when determining which patients are good candidates for the procedure. In this Q&A, Stephen Solomon, MD, reviews recently published trials, looks… Read More
In a prospective multi-centre randomized trial by Machi et al published in the Journal Medical Oncology (2017 May 10.1007/s12032-017-0946-x), radiofrequency ablation (RFA) and microwave ablation (MWA) are both found to be excellent in terms of efficacy and safety while MWA produced less… Read More
Newswise — BOSTON, September 26, 2016 -- Survival rates for elderly patients who received stereotactic body radiation therapy (SBRT) for early stage non-small cell lung cancer (NSCLC) rose from roughly 40% to 60% over the past decade, concurrent with the increasing adoption of SBRT, according to… Read More
Newswise — BOSTON, September 25, 2016 -- A new analysis of records in the Veteran’s Affairs Central Cancer Registry demonstrates a clear positive impact of the increased use of stereotactic body radiation therapy (SBRT) to treat patients with stage I non-small cell lung cancer (NSCLC) in recent… Read More